![]() ![]() In December 2016 ERT acquired Exco InTouch, a provider of patient engagement, data capture and digital health solutions. In March 2016 ERT was acquired by Nordic Capital, a private healthcare investment firm for about $1.8 Billion. On FebruERT acquired PHT Corporation (PHT). In November 2014 ERT acquired eClinical Insights (eCI), a provider of cloud-based clinical trials management software. On July 9, 2012, ERT acquired and merged with invivodata, a provider of ePRO ( electronic patient-reported outcomes) services and consulting. On July 3, 2012, ERT announced that Genstar Capital LLC of San Francisco acquired ERT in a take-private transaction valued at approximately $400 million. In May 2012, Biosigna was liquidized and the office in Munich was closed. Litwin oversaw ERT's global cardiac safety operations for seven years. Litwin joined ERT in 2000 as senior vice president and chief medical officer and was subsequently promoted in December 2005 to executive vice president and chief medical officer. was appointed ERT's new president and chief executive officer. In 2010, the then current CEO of ERT was replaced on an interim basis by Joel Morganroth, M.D. ![]() Along with the acquisition, ERT now has the capability to design and construct their own clinical diagnostic devices from a manufacturing facility in Estenfeld, Germany. This nearly doubled the company in size and brought a new service line and enhancements to its two current service offerings Respiratory Services, specializing in centralized spirometry, Multi-Mode ePRO for patient reported outcomes, and enhanced Cardiac Safety Solutions. In 2010 ERT acquired the Research Services Division of the CareFusion Corporation. In 2009 ERT ended its foray into the electronic data capture (EDC) business as ERT sold its EDC division for approximately $2.025 million of OmniComm shares. In 2008 ERT acquired Biosigna, a Munich-based company, which specialized in biomedical signal processing. In November 2021, ERT re-branded and the company name was changed to Clario. It offers centralized cardiac safety and respiratory efficacy services in drug development and also collects, analyzes and distributes electronic patient-reported outcomes (ePRO) in multiple modalities across all phases of clinical research. Our innovation has been transforming clinical trials for 50 years.ERT ( eResearchTechnology, Inc.) is a global company specializing in clinical services and customizable medical devices to biopharmaceutical and healthcare organizations. Clario's global team of science, technology and operational experts have helped deliver over 24,000 trials and contributed to over 500 FDA and EMEA new drug approvals involving more than five million patients in 120 countries. Clario has the only technology platform that combines eCOA, cardiac safety, medical imaging, precision motion, and respiratory endpoints. Across decentralized, hybrid and site-based trials, our deep scientific expertise, global scale and the broadest endpoint technology platform in the industry allows our partners to transform lives. Is a leading healthcare research and technology company that generates the richest clinical evidence in the industry for our pharmaceutical, biotech and medical device partners. ![]() This new offering is unmatched in the market, providing user-friendly image access minimizing cost, time and risk." "We have a long history of innovation in medical imaging for clinical trials. "We expect our Cloud-Based Image Viewer to greatly simplify and accelerate viewing images during clinical trials," The tool is data privacy compliant, enabling easy electronic image accessibility, and all within a streamlined, fully integrated process and platform. It provides viewing and manipulation tools for full-resolution, empowering the end users to gain valuable insights into their trial subjects. The tool streamlines the process and eliminates manual steps, making the image accessibility easy and secure. ![]() With the new Image Viewer tool, sponsors and CROs can access read-quality images in near real-time through an intuitive web-based imaging viewer. The Cloud-native Image Viewer is an innovative tool incorporating advanced usability features and is custom built working closely with our in-house radiologists specifically for Clinical Trial needs," "At Clario we are committed to accelerate Clinical Trials by solving complex problems and this world-class Image Viewer is a leap in that direction by providing powerful insights to Clients early on. Due to third-party access and allocation, most sponsors would have to wait until the end of the study phase or longer to view their images. Previously, to view images for a clinical trial, multiple groups were involved in the image transfer process, which added risk of delay and potential errors to an already complex process. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |